Clinical trial NCT05442307: Academic Detailing About Asthma
Official title: Boosting General Practice pRescription by Individual Educational Fast Academic Detailing Visits About Asthma
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Prescription Pattern
Lead sponsor: University Hospital Bispebjerg and Frederiksberg
Sponsor class: OTHER
First posted: 2022-07-05
Enrollment: 360
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: randomized placebo controlled study
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: General practices in the Capital Region of Denmark are offered a short educational visit and are randomized to either asthma (intervention) or another topic (control).

The change in prescription pattern from before to after the visit is compared between the intervention and control group.

Detailed description: General practices in the Capital Region of Denmark are offered a short educational visit. They are randomized by address to be offered a visit about either asthma (intervention) or another topic (control).

The prescription pattern of each general practice (as seen by their regional registration number \[ydernummer\]) who receive a visit is investigated.

The change in prescription pattern from before to after the visit is compared between the intervention and control group.

Eligibility criteria: Inclusion Criteria:

* General practices in the capital region of denmark, who owns a regional registration number \[ydernummer\]
* Want a visit
* Have time for a visit within the study period

Exclusion Criteria:

-

Primary outcomes:
measure: Difference in change of prescription of inhaled corticosteroids and long-acting beta2-agonist (ICS+LABA) before and after educational visit in a six months period
timeFrame: 6-0 months before and 6-12 months after educational visit
measure: Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit in a six months period
timeFrame: 6-0 months before and 6-12 months after educational visit
Secondary outcomes:
measure: Difference in change of prescription of ICS+LABA before and after educational visit in one year
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of ICS+LABA before and after educational visit in one year as interrupted time series analysis
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of ICS+LABA before and after educational visit in one year for each month
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year as interrupted time series analysis
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year for each month
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of the Easyhaler Device before and after educational visit in a six months period
timeFrame: 6-0 months before and 6-12 months after educational visit
measure: Difference in change of prescription of the Easyhaler Device before and after educational visit in one year
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of the Easyhaler Device before and after educational visit as interrupted time series analysis
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of the Easyhaler Device before and after educational visit for each month
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of long-acting muscarinic antagonist (LAMA) before and after educational visit in a six months period
timeFrame: 6-0 months before and 6-12 months after educational visit
measure: Difference in change of prescription of LAMA before and after educational visit in one year
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of LAMA before and after educational visit as interrupted time series analysis
timeFrame: one year before and one year after educational visit
measure: Difference in change of prescription of LAMA before and after educational visit for each month
timeFrame: one year before and one year after educational visit
measure: Difference in change of cost of each medication group before and after educational visit in a six months period
timeFrame: 6-0 months before and 6-12 months after educational visit
measure: Difference in change of cost of each medication group before and after educational visit in one year
timeFrame: one year before and one year after educational visit
measure: Difference in change of cost of each medication group before and after educational visit as interrupted time series analysis
timeFrame: one year before and one year after educational visit
measure: Difference in change of cost of each medication group before and after educational visit for each month
timeFrame: one year before and one year after educational visit
Other outcomes:
Locations:
city: Copenhagen
country: Denmark
facility: University Hospital Bispebjerg and Frederiksberg
state: Capital Region Of Denmark
Study officials:
affiliation: University Hospital Bispebjerg and Frederiksberg
name: Jon tt Andersen, MD
role: PRINCIPAL_INVESTIGATOR
References: